Sodium Bicarbonate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sodium Bicarbonate
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Sodium Bicarbonate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 17 USDMF, 5 CEP/COS, 6 JDMF, 2 EU WC, 7 KDMF, 14 NDC API, 12 Listed Suppliers, $ API Reference Price

37 API Suppliers
17 USDMF
5 CEP/COS
6 JDMF
2 EU WC
7 KDMF
14 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

295 FDF Dossiers, 113 FDA Orange Book, 87 Europe, 32 Canada, 2 Australia, 39 South Africa, 22 Listed Dossiers

295 FDF Dossiers
113 FDA Orange Book
87 Europe
32 Canada
2 Australia
39 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML, FOR SOLUTION;ORAL - 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT, INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), CAPSULE;ORAL - 20MG;1.1GM, CAPSULE;ORAL - 40MG;1.1GM, CAPSULE;ORAL - 20MG;1.1GM

SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
FOR SOLUTION;ORAL - 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT
INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)
INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
CAPSULE;ORAL - 20MG;1.1GM
CAPSULE;ORAL - 40MG;1.1GM
CAPSULE;ORAL - 20MG;1.1GM

RELATED EXCIPIENT COMPANIES

1 Minakem, 11 Rochem International Inc, 25 SPI Pharma, 11 DKSH, 2 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 21 BASF, 2 Bioplus Life Sciences, 1 Clariant, 5 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 10 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 26 Roquette, 10 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 39 Direct Compression, 32 Thickeners and Stabilizers, 32 Coating Systems & Additives, 31 Taste Masking, 30 Solubilizers, 25 Lubricants & Glidants, 24 Disintegrants & Superdisintegrants, 23 Parenteral, 23 Granulation, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 17 Topical, 16 Controlled & Modified Release, 13 Film Formers & Plasticizers, 10 Emulsifying Agents, 8 Empty Capsules, 6 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Rheology Modifiers, 3 Coloring Agents

74 Fillers, Diluents & Binders
39 Direct Compression
32 Thickeners and Stabilizers
32 Coating Systems & Additives
31 Taste Masking
30 Solubilizers
25 Lubricants & Glidants
24 Disintegrants & Superdisintegrants
23 Parenteral
23 Granulation
21 Chewable & Orodispersible Aids
19 Co-Processed Excipients
17 Topical
16 Controlled & Modified Release
13 Film Formers & Plasticizers
10 Emulsifying Agents
8 Empty Capsules
6 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Rheology Modifiers
3 Coloring Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 61 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
61 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 78 Finished Drug Prices

3 US Medicaid Prescriptions
78 Finished Drug Prices

MARKET PLACE

41 APIs, 10 FDF Dossiers, 2 EXCIPIENTS, 1 Intermediates

41 APIs
10 FDF Dossiers
2 EXCIPIENTS
1 Intermediates

PATENTS & EXCLUSIVITIES

7 US Patents

7 US Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

2 USP
1 Others

$ API Ref.Price (USD/KG) : 164 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 7AZURITY

filter Patent Number Reset all filters

7 All

01 110751333

02 111103492

03 111633478

04 111771686

05 211911473

06 112042539

filter API Patent Reset all filters

7 All

01 7Blank

filter FDF Patent Reset all filters

7 All

01 4Y

02 3Blank

filter Expiration Date Reset all filters

7 All

01 62039-07-16

02 12040-03-01

Product Main Page

01

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 11911473

Drug Substance Claim :

Drug Product Claim :

Application Number : 213593

Patent Use Code : U-623

Delist Requested :

Patent Use Description : SHORT TERM TREATMENT O...

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 11911473

Drug Substance Claim :

Drug Product Claim :

Application Number : 213593

Patent Use Code : U-624

Delist Requested :

Patent Use Description : REDUCTION OF RISK OF U...

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2040-03-01

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 11771686

Drug Substance Claim :

Drug Product Claim :

Application Number : 213593

Patent Use Code : U-623

Delist Requested :

Patent Use Description : SHORT TERM TREATMENT O...

Patent Expiration Date : 2040-03-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 10751333

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213593

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 11103492

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213593

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 11633478

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213593

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

AZURITY

OMEPRAZOLE; SODIUM BICARBONATE

Antibody Engineering

Not Confirmed

AZURITY

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-16

OMEPRAZOLE; SODIUM BICARBONATE

US Patent Number : 12042539

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213593

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?